Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate

Journal of Structural Biology

Volumn 176, Issue 3, 2011, Pages 307-314

  Venskutonyte, Raminta ^a   Frydenvang, Karla ^a   Gajhede, Michael ^a   Bunch, Lennart ^a   Pickering, Darryl S ^a   Kastrup, Jette S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dimerization; Ionotropic glutamate receptor; Ligand binding site; Receptor ligand interactions; X ray crystallography

Indexed keywords

GLUTAMIC ACID; IONOTROPIC RECEPTOR; PROTEIN GLUK1; PROTEIN GLUK2; PROTEIN GLUK3; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DATABASES, PROTEIN; GLUTAMIC ACID; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, KAINIC ACID;

EID: 80555150656     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2011.08.014     Document Type: Article

References (47)

1. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 2002, 58:1948-1954.
2. Alt A., Weiss B., Ogden A.M., Knauss J.L., Oler J., et al. Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro. Neuropharmacology 2004, 46:793-806.
3. Alushin G.M., Jane D., Mayer M.L. Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists. Neuropharmacology 2010, 60:126-134.
4. Armstrong N., Gouaux E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 2000, 28:165-181.
5. Armstrong N., Jasti J., Beich-Frandsen M., Gouaux E. Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor. Cell 2006, 127:85-97.
6. Atlason P.T., Scholefield C.L., Eaves R.J., Mayo-Martin M.B., Jane D.E., et al. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310. Mol. Pharmacol. 2010, 78:1036-1045.
7. Berrow N.S., Alderton D., Owens R.J. The precise engineering of expression vectors using high-throughput In-Fusion PCR cloning. Methods Mol. Biol. 2009, 498:75-90.
8. Chaudhry C., Weston M.C., Schuck P., Rosenmund C., Mayer M.L. Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization. EMBO J. 2009, 28:1518-1530.
9. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 1994, 50:760-763. Collaborative Computational Project, No.4.
10. Contractor A., Mulle C., Swanson G.T. Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci. 2011, 34:154-163.
11. Cui C., Mayer M.L. Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7. J. Neurosci. 1999, 19:8281-8291.
12. Dargan S.L., Clarke V.R., Alushin G.M., Sherwood J.L., Nisticò R., et al. ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function. Neuropharmacology 2009, 56:121-130.
13. Dimasi N., Flot D., Dupeux F., Márquez J.A. Expression, crystallization and X-ray data collection from microcrystals of the extracellular domain of the human inhibitory receptor expressed on myeloid cells IREM-1. Acta Crystallogr. F 2007, 63:204-208.
14. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 2004, 60:2126-2132.
15. Frandsen A., Pickering D.S., Vestergaard B., Kasper C., Nielsen B.B., et al. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2. Mol. Pharmacol. 2005, 67:703-713.
16. Frydenvang K., Lash L.L., Naur P., Postila P.A., Pickering D.S., et al. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine. J. Biol. Chem. 2009, 284:14219-14229.
17. Greenwood J.R., Mewett K.N., Allan R.D., Martin B.O., Pickering D.S. 3-Hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists. Neuropharmacology 2006, 51:52-59.
18. Hald H., Naur P., Pickering D.S., Sprogøe D., Madsen U., et al. Partial agonism and antagonism of the ionotropic glutamate receptor iGluR5: structures of the ligand-binding core in complex with domoic acid and 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl] propionic acid. J. Biol. Chem. 2007, 282:25726-25736.
19. Hayward S., Lee R.A. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50. J. Mol. Graph. Model. 2002, 21:181-183.
20. Hazes B., Dijkstra B.W. Model building of disulfide bonds in proteins with known three-dimensional structure. Protein Eng. 1988, 2:119-125.
21. Jane D.E., Lodge D., Collingridge G.L. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 2009, 56:90-113.
22. Jin R., Banke T.G., Mayer M.L., Traynelis S.F., Gouaux E. Structural basis for partial agonist action at ionotropic glutamate receptors. Nat. Neurosci. 2003, 6:803-810.
23. Kleywegt G.J., Jones T.A. Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D 1994, 50:178-185.
24. Krissinel E., Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007, 372:774-797.
25. Larsen A.M., Bunch L. Medicinal chemistry of competitive kainate receptor antagonists. ACS Chem. Neurosci. 2010, 2:60-74.
26. Larsen A.M., Venskutonyte R., Valadés E.A., Nielsen B., Pickering D.S., et al. Discovery of a new class of ionotropic glutamate receptor antagonists by the rational design of (2S,3R)-3-(3-carboxyphenyl)-pyrrolidine-2-carboxylic acid. ACS Chem. Neurosci. 2010, 2:107-114.
27. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. PROCHECK - a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 1993, 26:283-291.
28. Mayer M.L. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron 2005, 45:539-552.
29. Mayer M.L., Ghosal A., Dolman N.P., Jane D.E. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J. Neurosci. 2006, 26:2852-2861.
30. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., et al. Phaser crystallographic software. J. Appl. Crystallogr. 2007, 40:658-674.
31. Naur P., Vestergaard B., Skov L.K., Egebjerg J., Gajhede M., et al. Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate. FEBS Lett. 2005, 579:1154-1160.
32. Nayeem N., Mayans O., Green T. Conformational flexibility of the ligand-binding domain dimer in kainate receptor gating and desensitization. J. Neurosci. 2011, 31:2916-2924.
33. Perrais D., Coussen F., Mulle C. Atypical functional properties of GluK3-containing kainate receptors. J. Neurosci. 2009, 29:15499-15510.
34. Perrakis A., Morris R., Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 1999, 6:458-463.
35. Pinheiro P.S., Perrais D., Coussen F., Barhanin J., Bettler B., et al. GluR7 is an essential subunit of presynaptic kainate autoreceptors at hippocampal mossy fiber synapses. Proc. Natl Acad. Sci. USA 2007, 104:12181-12186.
36. Plested A.J., Vijayan R., Biggin P.C., Mayer M.L. Molecular basis of kainate receptor modulation by sodium. Neuron 2008, 12:720-735.
37. Rasmussen J.L., Storgaard M., Pickering D.S., Bunch L. Rational design, synthesis and pharmacological evaluation of the (2R)- and (2S)-stereoisomers of 3-(2-carboxypyrrolidinyl)-2-methyl acetic acid as ligands for the ionotropic glutamate receptors. ChemMedChem 2011, 6:498-504.
38. Sagot E., Pickering D.S., Pu X., Umberti M., Stensbøl T.B., et al. Chemo-enzymatic synthesis of a series of 2, 4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7. J. Med. Chem. 2008, 51:4093-4103.
39. Schiffer H.H., Heinemann S.F. Association of the human kainate receptor GluR7 gene (GRIK3) with recurrent major depressive disorder. Am. J. Med. Genet. B 2007, 144:20-26.
40. Schiffer H.H., Swanson G.T., Heinemann S.F. Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate. Neuron 1997, 19:1141-1146.
41. Sobolevsky A.I., Rosconi M.P., Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 2009, 462:745-756.
42. Swanson G.T., Gereau R.W., Green T., Heinemann S.F. Identification of amino acid residues that control functional behavior in GluR5 and GluR6 kainate receptors. Neuron 1997, 19:913-926.
43. The PyMOL Molecular Graphics System, Version 1.3. Schrödinger, LLC.
44. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 2010, 62:405-496.
45. Unno, M., Shinohara, M., Takayama, K., Teruya, K., Doh-ura, K., et al. Crystal structures of human GluR5 ligand-binding core in complex with novel marine-derived toxins, dysiherbaine and neodysiherbaine A, and their analogues. Deposited in the Protein Data Bank, release date 2010-01-19.
46. Weston M.C., Gertler C., Mayer M.L., Rosenmund C. Interdomain interactions in AMPA and kainate receptors regulate affinity for glutamate. J. Neurosci. 2006, 26:7650-7658.
47. Weston M.C., Schuck P., Ghosal A., Rosenmund C., Mayer M.L. Conformational restriction blocks glutamate receptor desensitization. Nat. Struct. Mol. Biol. 2006, 13:1120-1127.